Oberweis Asset Management Inc. Purchases 7,100 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Oberweis Asset Management Inc. raised its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 8.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 91,500 shares of the company's stock after purchasing an additional 7,100 shares during the period. Oberweis Asset Management Inc. owned about 0.11% of HealthEquity worth $8,779,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in HQY. Barclays PLC raised its position in shares of HealthEquity by 209.3% during the 3rd quarter. Barclays PLC now owns 166,492 shares of the company's stock valued at $13,628,000 after acquiring an additional 112,667 shares in the last quarter. Sanctuary Advisors LLC acquired a new stake in shares of HealthEquity during the third quarter worth $260,000. Wilmington Savings Fund Society FSB bought a new position in shares of HealthEquity in the 3rd quarter worth about $150,000. Franklin Resources Inc. boosted its holdings in shares of HealthEquity by 0.7% in the 3rd quarter. Franklin Resources Inc. now owns 1,640,215 shares of the company's stock valued at $139,369,000 after buying an additional 11,659 shares during the period. Finally, GAMMA Investing LLC grew its position in shares of HealthEquity by 32.9% during the 4th quarter. GAMMA Investing LLC now owns 1,248 shares of the company's stock valued at $120,000 after buying an additional 309 shares during the last quarter. 99.55% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. KeyCorp decreased their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a research note on Wednesday, April 16th. Wells Fargo & Company raised their target price on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group lowered their price target on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a research report on Thursday, March 27th. Barrington Research reiterated an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a research report on Friday, April 11th. Finally, Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and decreased their target price for the stock from $120.00 to $115.00 in a research report on Tuesday, March 25th. One equities research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, HealthEquity presently has an average rating of "Buy" and an average target price of $111.75.

Insider Buying and Selling at HealthEquity

In other news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total transaction of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the company's stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the transaction, the executive vice president now owns 56,655 shares in the company, valued at $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 20,381 shares of company stock valued at $1,781,432. 2.20% of the stock is owned by insiders.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $1.47 during trading on Monday, hitting $84.40. The stock had a trading volume of 823,666 shares, compared to its average volume of 773,229. The business has a fifty day moving average of $91.87 and a two-hundred day moving average of $96.59. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $115.59. The firm has a market cap of $7.30 billion, a P/E ratio of 77.43, a PEG ratio of 1.60 and a beta of 0.49. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.